The Kinsey Institute at Indiana University and sexual wellness brand Womanizer released headline results from a groundbreaking clinical study examining how masturbation can affect menopause symptoms in peri- and post-menopausal women across the United States. At baseline, 97% of participants reported at least one menopause-related symptom. After four weeks of Womanizer Next use, 92.9% of participants reported experiencing at least one menopausal symptom less frequently. While masturbation alone appeared beneficial, women who achieved orgasm showed the largest symptom reductions. While only 3% reported ever having a doctor discuss masturbation with them, 91% said they would be more likely to masturbate if they knew it could positively impact menopause symptoms and 79% said they would follow a doctor’s advice to do so. This research highlights a major gap between patient interest and clinical guidance. By documenting measurable benefits, this research aims to destigmatize self-pleasure and highlight sexual wellness as an integral part of menopause care.

WASHINGTON—Too many children and adults living with congenital heart disease (CHD) are being left behind by a system that doesn’t adequately value their care. That’s the message of a new policy statement from the Society for Cardiovascular Angiography & Interventions (SCAI) that highlights broken reimbursement models, undervalued procedures, and barriers to device innovation.  

The statement, “Economic Barriers to Interventional Cardiology Care for Adults and Children With Congenital Heart Disease and Potential Policy Solutions,” was published today in JSCAI. It calls for Medicaid payment parity, fairer valuation of CHD procedures, new compensation models, and faster pathways for pediatric device approval.  

The largest survey of its kind has found alarming differences in the quality of care and advice given to individuals receiving cosmetic injections in the UK.

Published in Aesthetic Surgery Journal Open Forum, the study involved a survey of 919 adults from across the UK who had undergone botulinum toxin treatment, commonly referred to by the brand name Botox.

Amongst the findings are that 9% said they were not provided with a written consent form, while only 28% recalled receiving advice on how to manage potential side effects.